Vik Chopra
Stock Analyst at Wells Fargo
(3.98)
# 629
Out of 4,732 analysts
27
Total ratings
58.33%
Success rate
12.79%
Average return
Main Sectors:
Stocks Rated by Vik Chopra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Maintains: Overweight | $88 → $95 | $90.80 | +4.63% | 8 | Dec 11, 2024 | |
| MASI Masimo | Maintains: Overweight | $171 → $193 | $172.29 | +12.02% | 7 | Dec 11, 2024 | |
| NPCE NeuroPace | Maintains: Overweight | $15 → $13 | $11.97 | +8.60% | 2 | Nov 13, 2024 | |
| NVST Envista Holdings | Initiates: Equal-Weight | $20 | $19.83 | +0.86% | 1 | Oct 8, 2024 | |
| SOLV Solventum | Maintains: Equal-Weight | $69 → $64 | $73.51 | -12.94% | 2 | Aug 9, 2024 | |
| CNMD CONMED | Maintains: Equal-Weight | $77 → $71 | $67.69 | +4.89% | 2 | Aug 1, 2024 | |
| ATEC Alphatec Holdings | Maintains: Overweight | $26 → $19 | $11.57 | +64.22% | 1 | Aug 1, 2024 | |
| IART Integra LifeSciences Holdings | Downgrades: Equal-Weight | $45 → $25 | $24.10 | +3.73% | 1 | May 7, 2024 | |
| ENOV Enovis | Maintains: Overweight | $73 → $79 | $46.63 | +69.42% | 3 | Feb 23, 2024 |
Globus Medical
Dec 11, 2024
Maintains: Overweight
Price Target: $88 → $95
Current: $90.80
Upside: +4.63%
Masimo
Dec 11, 2024
Maintains: Overweight
Price Target: $171 → $193
Current: $172.29
Upside: +12.02%
NeuroPace
Nov 13, 2024
Maintains: Overweight
Price Target: $15 → $13
Current: $11.97
Upside: +8.60%
Envista Holdings
Oct 8, 2024
Initiates: Equal-Weight
Price Target: $20
Current: $19.83
Upside: +0.86%
Solventum
Aug 9, 2024
Maintains: Equal-Weight
Price Target: $69 → $64
Current: $73.51
Upside: -12.94%
CONMED
Aug 1, 2024
Maintains: Equal-Weight
Price Target: $77 → $71
Current: $67.69
Upside: +4.89%
Alphatec Holdings
Aug 1, 2024
Maintains: Overweight
Price Target: $26 → $19
Current: $11.57
Upside: +64.22%
Integra LifeSciences Holdings
May 7, 2024
Downgrades: Equal-Weight
Price Target: $45 → $25
Current: $24.10
Upside: +3.73%
Enovis
Feb 23, 2024
Maintains: Overweight
Price Target: $73 → $79
Current: $46.63
Upside: +69.42%